Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why revisiting traditional frames of reference on firm-level capabilities is crucial to unlock benefits of digital transformation.
New evidence from Sub-Saharan Africa shows that public procurement policies improve domestic firm performance.
The pandemic is a reminder that investments in scientific, technological and productive capacities are necessary to build resilience in crises.